Concepedia

Hugo Bergugnat

HB

Statistics

Publications

4

Citations

130

H-Index

4

Active since

2022

Affiliations

Inserm(Current)

Assistance Publique – Hôpitaux de Paris

Hospices Civils de Lyon

Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers

Université Paris Cité

Hugo Bergugnat is an author at Inserm specializing in life sciences, acute lymphoblastic leukemia biology, and genetics.

ORCID

Publications per year

2022–2024

4

Publications

4

Concurrent <i>CDX2 cis</i>-deregulation and <i>UBTF::ATXN7L3</i> fusion define a novel high-risk subtype of B-cell ALL

Marie Passet, Rathana Kim, Stéphanie Gachet et al. · Blood · 2022 · 34 citations · Full text

, , +17

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia

Thibaut Leguay, Marc Delord, Cyril Šálek et al. · Journal of Clinical Oncology · 2024 · 34 citations

, , +16

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i> -Mutant Clonal Hematopoiesis

Rathana Kim, Hugo Bergugnat, Lise Larcher et al. · Blood Cancer Discovery · 2023 · 33 citations · Full text

, , +9

Genetic alterations and MRD refine risk assessment for <i>KMT2A</i>-rearranged B-cell precursor ALL in adults: a GRAALL study

Rathana Kim, Hugo Bergugnat, Cédric Pastoret et al. · Blood · 2023 · 29 citations · Full text

, , +11

1–4 of 4